On June 13, 2024, Chongqing Sanbo Management, a wholly-owned subsidiary of Sanbo Neurology, signed an equity transfer agreement with Honghai No.1, stipulating that Chongqing Sanbo Management will acquire 34% of Luoyang Sanbo's equity held by Honghai No. 1 at a price of 51.6426 million yuan. After the completion of the transaction, Chongqing Sanbo Management will hold 70% of the equity of Luoyang Sanbo.